Page last updated: 2024-10-30

labetalol and ADDH

labetalol has been researched along with ADDH in 3 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"To determine the functional development of children born after treatment of mild-to-moderate gestational hypertension with labetalol versus methyldopa, and no antihypertensive treatment."3.76Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. ( Eskes, TK; Gabreëls, FJ; Pasker-de Jong, PC; Pellegrino, A; van Gelder, MM; Zielhuis, GA, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitton, CA1
Steiner, MFC1
Aucott, L1
Pell, JP1
Mackay, DF1
Fleming, M1
McLay, JS1
Krause, I1
Cleper, R1
Kovalski, Y1
Sinai, L1
Davidovits, M1
Pasker-de Jong, PC1
Zielhuis, GA1
van Gelder, MM1
Pellegrino, A1
Gabreëls, FJ1
Eskes, TK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Use of Meditation as a Complementary Therapy in the Treatment of Gestational Hypertension[NCT03873194]47 participants (Actual)Interventional2019-04-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for labetalol and ADDH

ArticleYear
In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.
    Journal of hypertension, 2017, Volume: 35, Issue:11

    Topics: Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Birth Weight; Child; Child H

2017

Other Studies

2 other studies available for labetalol and ADDH

ArticleYear
Changes in behavior as an early symptom of renovascular hypertension in children.
    Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:11

    Topics: Angiography; Antihypertensive Agents; Atenolol; Attention Deficit Disorder with Hyperactivity; Child

2009
Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study.
    BJOG : an international journal of obstetrics and gynaecology, 2010, Volume: 117, Issue:9

    Topics: Antihypertensive Agents; Attention; Attention Deficit Disorder with Hyperactivity; Bed Rest; Child;

2010